Loading clinical trials...
Loading clinical trials...
AI Medical Interviewing and Diagnostic System Performance Evaluation: One-Shot Vision Differential Diagnosis (OSVDE) and Multi-Step Conversational Non-Inferiority (MSCNE) Evaluation.
Conditions
Interventions
AI Diagnostic System (AIMD.1)
Locations
1
United States
Nolla Health (Magic Health Inc.)
New York, New York, United States
Start Date
March 19, 2026
Primary Completion Date
September 19, 2026
Completion Date
September 19, 2026
Last Updated
March 25, 2026
NCT06761248
NCT05858970
NCT04651738
NCT04650711
NCT02834585
NCT02726594
Lead Sponsor
Magic Health Inc. (d.b.a. Nolla Health)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions